Medicare Enrolled

Dr. Robert Henihan, M.D.

Gastroenterology · Wilmington, NC
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
5115 OLEANDER DR, Wilmington, NC 28403
9103621011
Registered in NPPES since 2006
NPI: 1912950403 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Henihan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Henihan? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Henihan

Dr. Robert Henihan is a gastroenterology specialist in Wilmington, NC, with 20 years of NPI registration. Based on federal Medicare data, Dr. Henihan performed 1,141 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Henihan received a total of $7,439 from 46 pharmaceutical and/or device companies across 328 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Henihan is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ Top 20% volume in NC $7,439 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
1,141
Medicare services
Top 20% in NC for gastroenterology
Not available
Unique patients (not deduplicated)
$102
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Colonoscopy with biopsy
A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease.
194 $100 $1,047
Colon polyp removal with endoscopic snare
This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination.
184 $192 $1,349
Upper GI endoscopy with biopsy
A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities.
121 $63 $943
Normal saline infusion, 250 cc
Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid.
115 $1 $15
Intravenous chemotherapy infusion, 1 hour or less
Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete.
114 $95 $300
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
76 $84 $160
Colonoscopy for colorectal cancer screening, high risk
A colonoscopy performed to screen for colorectal cancer in individuals identified as being at high risk for the disease.
69 $168 $952
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
50 $108 $200
Esophageal dilation with guide wire and endoscope
A flexible endoscope is used to insert a guide wire into the esophagus, followed by dilation to widen the esophageal passage.
48 $112 $940
Upper endoscopy (EGD)
A diagnostic exam of the esophagus, stomach, and upper small bowel using a flexible endoscope.
38 $70 $893
Colonoscopy for colorectal cancer screening
A colonoscopy performed to screen for colorectal cancer in individuals who are not at high risk for the disease.
34 $172 $952
Complete blood count (CBC) with differential
An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells.
32 $7 $34
Colonoscopy
A diagnostic exam of the large bowel using a flexible endoscope to visualize the interior of the colon.
22 $133 $952
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
16 $60 $122
Balloon dilation of esophagus, stomach, or upper small bowel, less than 3.0 cm
A procedure using a flexible endoscope to widen a narrowed section of the esophagus, stomach, or upper small bowel with a balloon that is less than 3.0 cm in length.
14 $106 $932
Dilation of esophagus 14 $31 $253
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
20.1% high complexity
41.9% medium
38.0% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$7,439
Total received (2018-2024)
Avg $1,063/year across 7 years
Top 21% in NC for gastroenterology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
328
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,954
2023
$1,803
2022
$1,592
2021
$446
2020
$276
2019
$783
2018
$585

Payments by company (2024)

ABBVIE INC.
$649
Janssen Biotech, Inc.
$233
CONMED Corporation
$203
GENZYME CORPORATION
$131
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$109
Lilly USA, LLC
$87
Takeda Pharmaceuticals U.S.A., Inc.
$87
Intercept Pharmaceuticals, Inc.
$69
Gilead Sciences, Inc.
$52
Phathom Pharmaceuticals, Inc.
$51
Ardelyx, Inc.
$49
AIMMUNE THERAPEUTICS, INC.
$41
Ipsen Biopharmaceuticals, Inc
$39
QOL Medical, LLC
$33
CapsoVision, Inc.
$32
Alnylam Pharmaceuticals Inc.
$30
Madrigal Pharmaceuticals
$22
Regeneron Healthcare Solutions, Inc.
$20
Daiichi Sankyo Inc.
$19
Top 3 companies account for 55.5% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$1,930
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$675
Janssen Biotech, Inc.
$596
AbbVie, Inc.
$561
Boston Scientific Corporation
$363
Gilead Sciences, Inc.
$297
Takeda Pharmaceuticals U.S.A., Inc.
$271
PFIZER INC.
$270
CONMED Corporation
$203
Ferring Pharmaceuticals Inc.
$185
Medtronic, Inc.
$154
AbbVie Inc.
$141
GENZYME CORPORATION
$131
E.R. Squibb & Sons, L.L.C.
$117
Romark Laboratories, LC
$104
Ardelyx, Inc.
$96
Intercept Pharmaceuticals, Inc.
$95
BOSTON SCIENTIFIC CORPORATION
$88
Lilly USA, LLC
$87
Regeneron Healthcare Solutions, Inc.
$85
Celgene Corporation
$85
Alnylam Pharmaceuticals Inc.
$81
Nestle HealthCare Nutrition Inc.
$79
Ironwood Pharmaceuticals, Inc
$79
Merck Sharp & Dohme LLC
$76
Daiichi Sankyo Inc.
$65
UCB, Inc.
$59
Phathom Pharmaceuticals, Inc.
$51
QOL Medical, LLC
$45
AIMMUNE THERAPEUTICS, INC.
$41
Ipsen Biopharmaceuticals, Inc
$39
PENTAX of America, Inc.
$33
CapsoVision, Inc.
$32
Janssen Pharmaceuticals, Inc
$32
Lucid Diagnostics Inc.
$27
Madrigal Pharmaceuticals
$22
Organon LLC
$20
Micro-tech Endoscopy USA, Inc.
$17
Fresenius Kabi USA, LLC
$16
Amgen Inc.
$15
NESTLE HEALTHCARE NUTRITION INC.
$14
Braintree Laboratories, Inc.
$13
Ambu Inc.
$13
Synergy Pharmaceuticals Inc
$13
INTRA-SANA LABORATORIES
$12
Alexion Pharmaceuticals, Inc.
$12
Top 3 companies account for 43.0% of all-time payments
Associated products mentioned in payments ›
ALINIA · APRISO · AVSOLA · CAPTIVATOR · CONMED BILIARY · CREON · CapsoCam Plus · Cimzia · Creon · DIFICID · DUPIXENT · ENTYVIO · EXALT Model D · Entyvio · GATTEX · GIVLAARI · HUMIRA · Humira · IBSRELA · IDACIO · IMAGINA · INFLECTRA · INJECTAFER · INTERSTIM · IQIRVO · LINZESS · Linzess · Lockado · MAVYRET · Mavyret · OCALIVA · OMVOH · REBYOTA · RELISTOR · RELTONE 200 MG · RENFLEXIS · RESMETIROM · RINVOQ · SKYRIZI · SPYGLASS · STELARA · SUCRAID · SUTAB · SpyGlass · TREMFYA · TRULANCE · Trulance · UCERIS · Ultomiris · VIBERZI · VOQUEZNA · XELJANZ · XIFAXAN · XIFAXANIBSD · XIFIXAN · ZENPEP · ZEPOSIA
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a gastroenterology specialist in Wilmington?
Compare gastroenterologists in the Wilmington area by procedure volume, costs, and industry payment transparency.
Browse gastroenterologists nearby

Geographic Context

Gastroenterologists in nearby ZIP areas
18
County median income
$72,892
Nearest hospital to ZIP centroid (approximate)
WILMINGTON TREATMENT CENTER
7.1 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Henihan is a mixed practice specialist, with above-average Medicare volume (top 20% in NC), with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Henihan experienced with colonoscopy with biopsy?
Based on Medicare claims data, Dr. Henihan performed 194 colonoscopy with biopsy services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Henihan receive payments from pharmaceutical companies?
Yes. Dr. Henihan received a total of $7,439 from 46 companies across 328 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Henihan's costs compare to other gastroenterologists in Wilmington?
Dr. Henihan's average Medicare payment per service is $102. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Henihan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →